Area of research
Epidemiology · Hepatology
Research interest
Research focused on Immunogenicity and Adverse effect, with related work in Prostatectomy, Cirrhosis, Photodegradation. Notable publications include 'Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study', 'Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study', and 'A novel LaFeO3/g-C3N4/Ag3PO4 dual Z-scheme heterojunction with enhanced light absorption, charge carrier separation and transfer capacity for photodegradation of antibiotics'.
A novel LaFeO3/g-C3N4/Ag3PO4 dual Z-scheme heterojunction with enhanced light absorption, charge carrier separation and transfer capacity for photodegradation of antibiotics
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study
Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: A retrospective study
Preoperative Platelet Count Correlates With Postoperative Perineural Invasion on Specimen in Patients Treated With Radical Prostatectomy
Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study
High hepatitis C virus cure rates with approved interferon‐free direct‐acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b